Invesco S&P 500 Pure Value ETF

RPV · AMEX

Market closed$118.24$0.160000 (+0.14%)After hours $118.24 · 0.00%

Key statistics

Previous close$118.08
Open$118.40
Day high$119.78
Day low$117.87
52-week high$119.74
52-week low$90.30
Market cap1.67B
Volume134.84K
Average volume139.55K
P/E ratio16.92
Forward P/E
EPS6.99
Dividend yield0.00%

Market context

Why it moved

RPV experienced a modest uptick today, likely driven by broad value equity buying interest as investors rotated into value-oriented ETFs amid stable market conditions.

What is happening

Recent company-specific developments and publisher coverage.

July 17, 2026The Invesco S&P 500 Pure Value ETF closed little changed on Friday, holding steady even as the broader S&P 500 fell roughly 1% amid a sharp tech-led selloff driven by China's Moonshot AI unveiling Kimi K3, its most powerful open-source model, which rattled AI spending optimism and sent semiconductor stocks into a technical bear market. RPV's value-oriented tilt — with top holdings in managed care (Humana, CVS, Cigna), consumer staples (ADM), autos (GM, Ford), and retail (Target) — provided a buffer from the tech rout, as investors rotated into financials and non-tech sectors. Managed care names in the portfolio benefited from UnitedHealth's strong Q2 earnings beat and guidance raise, while the financials sector (XLF) posted a strong week on broad bank earnings outperformance.

0.1355

July 16, 2026The Invesco S&P 500 Pure Value ETF edged higher, touching a fresh 52-week high of $118.44 during Thursday's session, as value-oriented stocks received a notable boost from UnitedHealth's blowout Q2 earnings — reporting adjusted EPS of $6.38 versus the $4.90 estimate — which lifted managed care names like Humana and Cigna that are among the ETF's top holdings. The supportive macro backdrop of cooling inflation (June CPI at 3.5% year-over-year, down from 4.2%) and strong bank earnings from Goldman Sachs, JPMorgan, and Morgan Stanley further buoyed the fund's financials-heavy portfolio, even as the broader S&P 500 closed slightly lower as chip stock weakness offset broad-based value gains.

0.7939

July 15, 2026The Invesco S&P 500 Pure Value ETF closed modestly lower, slipping as several of its top healthcare holdings faced headwinds — Progressive declined on a JPMorgan downgrade citing valuation concerns, while managed care names saw mixed sentiment. Despite the slight dip, the fund is trading close to its 52-week high and has surged roughly 25% over the past year, benefiting from an ongoing market rotation away from expensive growth and AI-heavy tech into value-oriented names. Strong Q2 earnings from major banks and a cooler-than-expected inflation print provided a supportive macro backdrop, with Wells Fargo upgrading Humana to Buy with a $502 target adding further tailwinds to the fund's top holdings.

-0.2214

July 15, 2026The Invesco S&P 500 Pure Value ETF closed modestly lower, pulling back slightly from its 52-week high of $118.21 amid a volatile session shaped by a cooler-than-expected June CPI report and a strong round of bank earnings. Key holdings Humana and Cigna were notable bright spots — Humana surged on a Wells Fargo upgrade to Buy with a $502 price target, while Cigna rose on pre-earnings optimism — helping offset pressure from Progressive, which fell after a worse-than-expected combined ratio. The broader financial sector (XLF) saw elevated volume as Goldman Sachs jumped over 7% on blowout Q2 results, reinforcing value-oriented investor appetite for financials and cyclicals heading into the thick of earnings season.

-0.2633

July 13, 2026The Invesco S&P 500 Pure Value ETF rose nearly 1% to close near its 52-week high, outperforming the broader S&P 500 as investors rotated toward value-oriented names amid a mixed market backdrop dominated by chip stock weakness and U.S.-Iran tensions. Several top RPV holdings provided meaningful tailwinds: CVS Health gained on strong earnings momentum and a fresh dividend declaration, Cigna surged over 3%, Humana climbed on improved Medicare Advantage sentiment, and Dow Inc. rose on a stronger second-quarter outlook — all helping the fund offset headwinds from tech-sensitive sectors and elevated oil prices ahead of a busy earnings season.

0.9865

July 10, 2026The Invesco S&P 500 Pure Value ETF closed modestly higher, approaching its 52-week high, as value-oriented sectors outperformed against a backdrop of a choppy market session. Key holdings drove the narrative: Centene (CNC, top holding at 2.8%) secured a new Illinois Medicaid contract, reinforcing analyst optimism around Medicaid margin recovery, while CVS Health (CI, 2.1% holding) benefited from CEO commentary indicating Aetna has medical costs under control ahead of Q2 earnings. The broader market showed a clear split between growth and value, with Dow Jones futures rising earlier in the week as capital rotated from tech into financials, energy, and industrials — sectors heavily represented in RPV's holdings.

0.5954

July 9, 2026The Invesco S&P 500 Pure Value ETF edged modestly higher on Thursday, outperforming the broader S&P 500 as investors rotated into value-oriented names amid geopolitical uncertainty. Several of RPV's top holdings — including Centene, CVS Health, Humana, and Cigna — saw constructive analyst activity, with RBC raising its Humana price target to $415 and Bernstein lifting its Cigna target to $381, while CVS's CEO signaled confidence in Aetna's medical cost management ahead of Q2 earnings. The fund trades near its 52-week high as a rotation from tech toward energy, financials, and healthcare continues against a backdrop of elevated oil prices and US-Iran tensions reigniting inflation concerns.

0.2943

July 9, 2026The Invesco S&P 500 Pure Value ETF closed modestly lower, weighed down by a sharp escalation in U.S.-Iran tensions after President Trump declared the ceasefire agreement "over," sending oil prices surging more than 6% and triggering a broad risk-off sell-off. The ETF's top holdings — including managed care names Centene and Humana, chemicals giant Dow, and consumer staples Ford and CVS — all faced headwinds, as rising Treasury yields, inflation fears ahead of the Fed's June meeting minutes, and sector-specific pressures on healthcare and industrials compounded the macro-driven weakness. The financial sector (XLF) also pulled back sharply, reflecting concerns that tighter monetary policy could follow renewed oil-driven inflation.

-0.5252

Peers